Search Results - "Garrido López, Pilar"

Gender inequity in the medical profession: the women doctors in Spain (WOMEDS) study by Santucci, Claudia, López-Valcarcel, Beatriz González, Avendaéo-Solá, Cristina, Bautista, Mari Carmen, Pino, Carmen Gallardo, García, Lourdes Lledó, Martín-Perez, Elena, López, Pilar Garrido

“…Abstract Background The long-standing underrepresentation of women in leadership positions in medicine is well-known, but poorly documented globally. There is…”
Get full text

Case Report: Precision genetic diagnosis in a case of Dyggve-Melchior-Clausen syndrome reveals paternal isodisomy and heterodisomy of chromosome 18 with imprinting clinical implications by López-Garrido, María-Pilar, Carrascosa-Romero, María-Carmen, Montero-Hernández, Minerva, Serrano-Martínez, Caridad-María, Sánchez-Sánchez, Francisco

“…A twelve-year-old patient with a previous clinical diagnosis of spondylocostal skeletal dysplasia and moderate intellectual disability was genetically analyzed…”
Get full text

SWATH-MS Quantitative Proteomic Analysis of Deer Antler from Two Regenerating and Mineralizing Sections by López-Pedrouso, María, Lorenzo, José, Landete-Castillejos, Tomás, Chonco, Louis, Pérez-Barbería, Francisco, García, Andrés, López-Garrido, María-Pilar, Franco, Daniel

“…Antlers are the only organ in the mammalian body that regenerates each year. They can reach growth rates of 1–3 cm/day in length and create more than 20…”
Get full text

Null CYP1B1 Genotypes in Primary Congenital and Nondominant Juvenile Glaucoma by López-Garrido, María-Pilar, PhD, Medina-Trillo, Cristina, MS, Morales-Fernandez, Laura, MD, Garcia-Feijoo, Julián, MD, PhD, Martínez-de-la-Casa, José-María, MD, PhD, García-Antón, Maite, MS, Escribano, Julio, PhD

“…Purpose To assess the mutation spectrum, enzymatic activity, and phenotypic features associated with CYP1B1 genotypes in primary congenital glaucoma (PCG) and…”
Get full text

Efficacy of immunotherapy in sarcomatoid lung cancer, a case report and literature review by Kotlowska, Magda Palka, Rueda, Ana Gómez, Olmedo, María Eugenia, Benito, Amparo, Roldán, Almudena Santón, Fernandez Méndez, Maria Angeles, Gorospe, Luis, Palacios, José, Garrido López, Pilar

“…Sarcomatoid carcinoma is a subtype of non-small cell lung cancer (NSCLC) characterized by mesenchymal – epithelial transition component and awful prognosis. In…”
Get full text

Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility by Salinas-Sánchez, Antonio S, Donate-Moreno, María J, López-Garrido, María-Pilar, Giménez-Bachs, José M, Escribano, Julio

“…CYP1B1 activates procarcinogens in some human tissues, including the urinary tract. Changes related to genetic polymorphisms are a known risk factor for…”
Get more information

Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group by Cervantes, Francisco, López-Garrido, Pilar, Montero, María-Isabel, Jonte, Fermín, Martínez, Jesús, Hernández-Boluda, Juan-Carlos, Calbacho, María, Sureda, Anna, Pérez-Rus, Gloria, Nieto, José B, Pérez-López, Cristina, Román-Gómez, José, González, Marcos, Pereira, Arturo, Colomer, Dolors

“…Despite the favorable results of imatinib front line in chronic-phase chronic myeloid leukemia there is room for improvement. Early intervention during…”
Get full text

Brief Report: Evidence of Autism Spectrum Disorder Caused by a Mutation in ATRX Gene: A Case Report by López-Garrido, María-Pilar, Carrascosa-Romero, María-Carmen, Montero-Hernández, Minerva, Ruiz-Almansa, Jesús, Sánchez-Sánchez, Francisco

“…ATRX mutations are commonly associated with alpha-thalassaemia mental retardation syndrome (ATR-X syndrome) with a notable variable expressivity. This X-linked…”
Get full text

Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions by Ocaña, Carmen Vallejo, López, Pilar Garrido, Trueba, Ignacio Muguruza

“…Lung cancer is the most frequent cause of cancer death worldwide and its global incidence has been steadily increasing during recent decades. A third of…”
Get full text

CYP1B1 mutations in Spanish patients with primary congenital glaucoma: phenotypic and functional variability by Campos-Mollo, Ezequiel, López-Garrido, María-Pilar, Blanco-Marchite, Cristina, Garcia-Feijoo, Julián, Peralta, Jesús, Belmonte-Martínez, José, Ayuso, Carmen, Escribano, Julio

“…To analyze the contributions of cytochrome P4501B1 (CYP1B1) mutations to primary congenital glaucoma (PCG) in Spanish patients. We analyzed, by polymerase…”
Get full text

A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma by van Brummelen, Emilie M. J., Levchenko, Evgeny, Dómine, Manuel, Fennell, Dean A., Kindler, Hedy L., Viteri, Santiago, Gadgeel, Shirish, López, Pilar Garrido, Kostorov, Vladimir, Morgensztern, Daniel, Orlov, Sergey, Zauderer, Marjorie G., Vansteenkiste, Johan F., Baker-Neblett, Katherine, Vasquez, James, Wang, Xiaowei, Bellovin, David I., Schellens, Jan H. M., Yan, Li, Mitrica, Ionel, DeYoung, M. Phillip, Trigo, José

“…Summary Background Fibroblast growth factors (FGFs) have a fundamental role in cancer. Sequestering FGFs with GSK3052230 (FP-1039) blocks their ability to…”
Get full text

Nivolumab-induced pneumonitis complicated by cyst formation by Gorospe, Luis, Ayala-Carbonero, Ana María, Olmedo-García, María Eugenia, Gómez-Rueda, Ana, Palka, Magda, Mezquita, Laura, Garrido-López, Pilar

Get full text

Genotype–Phenotype Analysis of Bietti Crystalline Dystrophy in a Family with the CYP4V2 Ile111Thr Mutation by García-García, Gerardo-Pedro, López-Garrido, María-Pilar, Martínez-Rubio, Magdalena, Moya-Moya, Medina-Azahara, Belmonte-Martínez, José, Escribano, Julio

“…PURPOSE:The purposes of this study were to evaluate the genotypic and phenotypic correlations of Bietti crystalline dystrophy and to investigate the utility of…”
Get full text

WDR36 and P53 gene variants and susceptibility to primary open-angle glaucoma: analysis of gene-gene interactions by Blanco-Marchite, Cristina, Sánchez-Sánchez, Francisco, López-Garrido, María-Pilar, Iñigez-de-Onzoño, Mercedes, López-Martínez, Francisco, López-Sánchez, Enrique, Alvarez, Lydia, Rodríguez-Calvo, Pedro-Pablo, Méndez-Hernández, Carmen, Fernández-Vega, Luis, García-Sánchez, Julián, Coca-Prados, Miguel, García-Feijoo, Julián, Escribano, Julio

“…To investigate the role of WDR36 and P53 sequence variations in POAG susceptibility. The authors performed a case-control genetic association study in 268…”
Get full text

Role of MYOC and OPTN sequence variations in Spanish patients with primary open-angle glaucoma by Lopez-Martinez, Francisco, Lopez-Garrido, Maria-Pilar, Sanchez-Sanchez, Francisco, Campos-Mollo, Ezequiel, Coca-Prados, Miguel, Escribano, Julio

“…To retrospectively investigate the contribution of myocilin (MYOC) and optineurin (OPTN) sequence variations to adult-onset ocular hypertension (OHT) and…”
Get full text

SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated edition by Trigo Pérez, José Manuel, Garrido López, Pilar, Felip Font, Enriqueta, Isla Casado, Dolores

“…The purpose of this article is to provide updated recommendations for the diagnosis and treatment of patients non-small-cell lung cancer (NSCLC). The staging…”
Get full text

Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study by Sánchez-Guijo, Fermin M, Durán, Soledad, Galende, Josefina, Boqué, Concepción, Nieto, José B, Balanzat, Josep, Gracia, Antonio, García, Isabel, Avellaneda-Molina, Carmen, Moreno, María-Victoria, Luño-Fernandez, Elisa, Hermosilla, Mar, Sanchez-Varela, José Manuel, Dios, Ana, López-Garrido, Pilar, Giraldo, Pilar, Bargay, Joan, Domingo, José María, Soler, Alfonso, Salinas, Ramón, del Cañizo, Maria-Consuelo

“…Abstract Imatinib mesylate (IM) is the treatment of choice in patients with newly diagnosed chronic myeloid leukemia (CML), irrespectively of their age…”
Get full text

Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity by Honrubia-Gómez, Paloma, López-Garrido, María-Pilar, Gil-Gas, Carmen, Sánchez-Sánchez, José, Alvarez-Simon, Carmen, Cuenca-Escalona, Jorge, Perez, Ana Ferrer, Arias, Enrique, Moreno, Raul, Sánchez-Sánchez, Francisco, Ramirez-Castillejo, Carmen

“…Relapse after chemotherapy treatment depends on the cancer initiating cells (CICs). PEDF (Pigmented Epithelium Derived Factor) is an anti-angiogenic,…”
Get full text

Early Optimization of Imatinib Therapy in Patients Newly Diagnosed with Chronic-Phase Chronic Myeloid Leukemia (CP-CML). A Study of the Spanish PETHEMA Group by Cervantes, Francisco, López-Garrido, Pilar, Montero, María-Isabel, Jonte, Fermín, Martinez, Jesus, Hernández-Boluda, Juan-Carlos, Calbacho, María, Sureda, Anna, Pérez-Rus, Gloria, Nieto, José, Pérez-López, Cristina, Román, José, González, Marcos, Pereira, Arturo, Colomer, Dolors

“…Abstract 1113 Poster Board I-135 Currently, imatinib (IM) 400 mg daily is the frontline therapy for patients with CP-CML. In an attempt to improve the…”
Get full text

Metronomics for thymic carcinoma by Del Toro, Jacobo Muñoz, Castedo, Patricia Cortez, Salgado, Alfonso Cortés, García, M Eugenia Olmedo, López, Pilar Garrido

“…Although thymomas are the most frequent primary tumours of the anterior mediastinum, thymic carcinoma is very infrequent and more aggressive. Combination…”
Get full text